Atlas Trials

Refractory Tumor

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Tumor

RecordFirmDate
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance (NCT06202599)Peking University People's Hospital2021-11-25
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors (NCT04900519)Sorrento Therapeutics, Inc.2021-11-24
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers (NCT05099549)NKGen Biotech, Inc.2021-11-03
9-ING-41 in Pediatric Patients With Refractory Malignancies. (NCT04239092)Actuate Therapeutics Inc.2020-06-05
Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 (NCT03158324)National University Hospital, Singapore2017-05-22
Efficacy and Safety of Precision Therapy in Refractory Tumor (NCT03239015)Baodong Qin2017-01-01
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors (NCT02564198)Eli Lilly and Company2015-12-11
Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts (NCT03415477)Peking University People's Hospital2014-01-01

Track Refractory Tumor automatically

Every clearance here is in the API, with alerts when new ones post.